CVS Health: reduces guidance for 2024

(CercleFinance.com) - CVS Health has lowered its targets for 2024, expecting adjusted EPS of at least $8.
30 (instead of at least $8.50) and cash flow from operations of at least $12bn (instead of at least $12.5bn).

Over Q4 2023, the drugstore chain's adjusted EPS rose 4% to $2.12 and its adjusted operating profit increased by 3.6% to $4.23bn, on revenues that are up 11.9% at nearly $93.8bn.

The group posted FY adjusted EPS of $8.74 and revenues of $357.8bn, slightly above its respective target ranges of $8.50 to $8.70 and $351.5bn to $357.3bn.


Copyright (c) 2024 CercleFinance.com. All rights reserved.